题名 | Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure. |
作者 | Fox K1, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R. |
杂志 | Am Heart J. |
年|卷|期 | 2013 Oct;166(4): |
页码 | 654-661.e6. |
链接 | http://www.ncbi.nlm.nih.gov/pubmed/24093844 |
欢迎光临 科研速递论坛 (http://www.expaper.cn/) | Powered by Discuz! X2.5 |